Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -51.68% is 30% above its 4-year average of -74.22%, near the high end of its 4-year range (-260.57%–-8.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 50.32% above its 12-month average of -104.01%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -51.68%.
RETURN ON INVESTED CAPITAL (ROIC)
-51.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-104.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-80.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-74.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+50.32%
CURRENT VS 3Y AVG
+36.13%
CURRENT VS 5Y AVG
+30.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-44.97%
vs the sector median at left
P3 Health Partners Inc.
Market Cap
$18.80M
Return on Invested Capital (ROIC)
-51.68%
TTM Avg
-104.01%
3Y Avg
-80.91%
5Y Avg
-74.22%
Market Cap
$18.81M
Return on Invested Capital (ROIC)
-49.83%
TTM Avg
-1.54%
3Y Avg
-82.67%
5Y Avg
-67.29%
Market Cap
$19.14M
Return on Invested Capital (ROIC)
-1489.99%
TTM Avg
-2573.36%
3Y Avg
-1757.31%
5Y Avg
-1757.31%
Market Cap
$17.99M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
Market Cap
$17.74M
Return on Invested Capital (ROIC)
-73.92%
TTM Avg
-122.57%
3Y Avg
-184.65%
5Y Avg
-161.38%
Market Cap
$17.57M
Return on Invested Capital (ROIC)
-46.69%
TTM Avg
-40.71%
3Y Avg
-34.73%
5Y Avg
-24.39%
Market Cap
$20.16M
Return on Invested Capital (ROIC)
-259.91%
TTM Avg
-114.62%
3Y Avg
-82.11%
5Y Avg
-62.05%
Market Cap
$17.07M
Return on Invested Capital (ROIC)
-57.74%
TTM Avg
-38.37%
3Y Avg
-49.64%
5Y Avg
-45.59%
Market Cap
$16.77M
Return on Invested Capital (ROIC)
-88.07%
TTM Avg
-68.32%
3Y Avg
-78.67%
5Y Avg
-76.64%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| P3 Health Partners Inc. (PIII) | $18.80M | -51.68% | -104.01% | -80.91% | -74.22% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.81M | -49.83% | -1.54% | -82.67% | -67.29% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.14M | -1489.99% | -2573.36% | -1757.31% | -1757.31% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | N/A | -171.06% | -106.73% | -106.73% |
| PAVmed Inc. (PAVM)vs › | $17.74M | -73.92% | -122.57% | -184.65% | -161.38% |
| Cosmos Health Inc. (COSM)vs › | $17.57M | -46.69% | -40.71% | -34.73% | -24.39% |
| NextCure, Inc. (NXTC)vs › | $20.16M | -259.91% | -114.62% | -82.11% | -62.05% |
| Lipocine Inc. (LPCN)vs › | $17.07M | -57.74% | -38.37% | -49.64% | -45.59% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.77M | -88.07% | -68.32% | -78.67% | -76.64% |
| Palatin Technologies, Inc. (PTN)vs › | $16.73M | -125.44% | -125.44% | -1118.57% | -719.84% |
ROIC
-51.7%
ROE
-136.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -51.68% |
| 2026-03-31 | -111.93% |
| 2025-12-31 | -172.80% |
| 2025-09-30 | -82.78% |
| 2025-06-30 | -100.85% |
| 2025-03-31 | -89.56% |
| 2024-12-31 | -88.81% |
| 2024-09-30 | -57.54% |
| 2024-06-30 | -32.00% |
| 2024-03-31 | -31.11% |
| 2023-12-31 | -29.90% |
| 2023-09-30 | -101.69% |
| 2023-06-30 | -101.19% |
| 2023-03-31 | -260.57% |
| 2022-12-31 | -245.17% |
| 2022-09-30 | -99.07% |
| 2022-06-30 | -91.52% |
| 2022-03-31 | -10.69% |
| 2021-12-31 | -8.67% |
| 2020-12-31 | -179.69% |
